BioAdvance Revenue and Competitors
Estimated Revenue & Valuation
- BioAdvance's estimated annual revenue is currently $10.2M per year.
- BioAdvance's estimated revenue per employee is $193,019
Employee Data
- BioAdvance has 53 Employees.
- BioAdvance grew their employee count by -2% last year.
BioAdvance's People
Name | Title | Email/Phone |
---|---|---|
1 | Partner | Reveal Email/Phone |
2 | Partner | Reveal Email/Phone |
BioAdvance Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 15 | -32% | N/A | N/A |
#10 | $10.1M | 48 | -9% | N/A | N/A |
What Is BioAdvance?
BioAdvance is a biotechnology company based out of United States.
keywords:N/AN/A
Total Funding
53
Number of Employees
$10.2M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioAdvance News
2022-04-19 - Global Blood-Brain Barrier Transport Drugs Market to See ...
Cyclenium, BioAdvance, EIP Pharma, Bioasis Ripon College Days...
2022-04-17 - Adge Pharma, Cyan Bio advance treatments for rare ...
Adge Pharma, Cyan Bio advance treatments for rare paediatric diseases in Asian countries. 26 April 2022 | News...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.6M | 53 | 18% | N/A |
#2 | $6.9M | 53 | 20% | N/A |
#3 | $7.4M | 53 | 6% | $2.3M |
#4 | $9.8M | 53 | 8% | N/A |
#5 | $11.9M | 53 | 15% | N/A |